Editor's note: This story has been updated with additional information on Pear's financial state. The assets of prescription digital therapeutics maker Pear Therapeutics have been broken up and sold ...
Medical device company Sky Labs, known for its blood pressure monitoring ring, has started preparing for an initial public offering in South Korea after filing for a KOSDAQ listing with the country's ...
Payerset’s Research Assistant helps providers compare negotiated rates and analyze pricing data to inform contract ...
The virtual clinic plans to expand its clinician network, develop AI workflows and extend its deprescribing model to ...
The Connected Health Initiative’s proposed framework calls for shared responsibility, human review of higher-risk decisions ...
The company will expand its platform to identify additional conditions and grow its engineering, sales, customer success and ...
Deloitte identified potential growth in U.S. women’s healthcare spending by 2030, driven by earlier diagnosis, prevention and ...
The Series B funding will be used to support preclinical testing of genetic payloads and gene delivery technologies as well ...
Upcoming Medicare Advantage star ratings changes could affect plan payments and market participation, says David Bender, ...
The integration lets patients use digital credentials to confirm their identity when requesting medical records through ...
The company said it will charge $4 per renewal, and a Utah-licensed physician will review and authorize each prescription.
Health Care Without Harm CEO Emily Bancroft discusses how hospitals can use their purchasing power to reduce the ...